These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23483452)

  • 1. Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis.
    Weng Y; Chen Y; Chen J; Liu Y; Bao T
    Med Oncol; 2013 Jun; 30(2):531. PubMed ID: 23483452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
    Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
    BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors.
    Amirnasr A; Verdijk RM; van Kuijk PF; Kartal P; Vriends ALM; French PJ; van Royen ME; Taal W; Sleijfer S; Wiemer EAC
    Sci Rep; 2020 Feb; 10(1):2927. PubMed ID: 32076030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
    Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
    J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.
    Presneau N; Eskandarpour M; Shemais T; Henderson S; Halai D; Tirabosco R; Flanagan AM
    Br J Cancer; 2013 Mar; 108(4):964-72. PubMed ID: 23175151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4).
    Itani S; Kunisada T; Morimoto Y; Yoshida A; Sasaki T; Ito S; Ouchida M; Sugihara S; Shimizu K; Ozaki T
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1501-9. PubMed ID: 22526161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.
    Hummel TR; Jessen WJ; Miller SJ; Kluwe L; Mautner VF; Wallace MR; Lázaro C; Page GP; Worley PF; Aronow BJ; Schorry EK; Ratner N
    Clin Cancer Res; 2010 Oct; 16(20):5048-57. PubMed ID: 20739432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
    Sundby RT; Szymanski JJ; Pan AC; Jones PA; Mahmood SZ; Reid OH; Srihari D; Armstrong AE; Chamberlain S; Burgic S; Weekley K; Murray B; Patel S; Qaium F; Lucas AN; Fagan M; Dufek A; Meyer CF; Collins NB; Pratilas CA; Dombi E; Gross AM; Kim A; Chrisinger JSA; Dehner CA; Widemann BC; Hirbe AC; Chaudhuri AA; Shern JF
    Clin Cancer Res; 2024 Oct; 30(19):4363-4376. PubMed ID: 39093127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population.
    Weng Y; Chen Y; Chen J; Liu Y; Bao T
    Cancer Epidemiol; 2013 Dec; 37(6):913-6. PubMed ID: 23763827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion.
    Yan B; Meng X; Shi B; Shi J; Qin Z; Wei P
    J Neurooncol; 2012 Aug; 109(1):205-11. PubMed ID: 22528792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
    Friedrich RE; Kluwe L; Fünsterer C; Mautner VF
    Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors.
    Gong M; Ma J; Li M; Zhou M; Hock JM; Yu X
    Neuro Oncol; 2012 Aug; 14(8):1007-17. PubMed ID: 22718995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.